Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: Comparison with interleukin-8

Scandinavian Journal of Infectious Diseases

Volumn 31, Issue 2, 1999, Pages 185-189

  Engel, Andreas ^a   Steinbach, Gerald ^a   Kern, Peter ^a   Kern, Winfried V ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; PROCALCITONIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL TRIAL; DIAGNOSTIC VALUE; FEVER; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEUTROPENIA; STATISTICS;

ADOLESCENT; ADULT; AGED; BACTEREMIA; CALCITONIN; FEVER OF UNKNOWN ORIGIN; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INTERLEUKIN-8; MIDDLE AGED; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY;

EID: 0032857591     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655499750006254     Document Type: Article

References (21)

1. Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997; 25: 551-73.
2. Ligtenberg PC, Hoepelman IM, Sogtoen ACO, Dekker AW, van der Tweel I, Rozenberg-Arska M, et al. C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients. Eur J Clin Microbiol Infect Dis 1991; 10: 25-31.
3. Katz JA, Mustafa MM, Bash RO, Cash JV, Buchanan GR. Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer. Pediatr Infect Dis J 1992; 11: 708-12.
4. Manian FA. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia. Clin Infect Dis 1995; 21: 114-21.
5. Heney D, Lewis IJ, Evans SW, Banks R, Bailey CC, Whicher JT. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis 1992; 165: 886-90.
6. Cebon J, Layton JE, Maher D, Morstyn G. Endogenous haemopoietic growth factors in neutropenia and infection. Br J Haematol 1994; 86: 265-74.
7. Steinmetz HT, Herbertz A, Bertram M, Diehl V. Increase in interleukin-6 serum level preceding fever in granulocytopenia and correlation with death from sepsis. J Infect Dis 1995; 171: 225-8.
8. Günther G, Gardlund B, Hast R, Kimby E, Nordin M, Wretlind B. Endotoxaemia and inflammatory mediators in febrile patients with haematological disease. J Intern Med 1995; 237: 27-33.
9. Engel A, Mack E, Kern P, Kern WV. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever. Gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection 1998: 26: 213-9.
10. Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K. Procalcitonin-a new indicator of the systemic response to severe infections. Infection 1997; 25: 329-34.
11. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-8.
12. Gendrel D, Raymond J, Assicot M, Moulin F, Iniguez JL, Lebon P, Bohuon C. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997; 24: 1240-2.
13. de Werra I, Jaccard C, Corradin SB, Chiolero R, Yersin B, Gallati H, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparison in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25: 607-13.
14. Al-Nawas B, Shah PM. Procalcitonin in patients with and without immunosuppression and sepsis. Infection 1996; 24: 434-6.
15. Fleischhack G, Cipic D, Kambeck I, NGampolo D, Hasan C, Bode U. Procalcitonin - a sensitive marker of severe infections in neutropenic patients. 3rd International Symposium on Febrile Neutropenia, Brussels, Belgium, 1997, abstract 12.
16. Bernard L, Fernere F, Casassus P, Malas F, Leveque S, Guillevin L, Lortholary O. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis 1998; 27: 914-5.
17. Grecka P, Anargyrou K, Poulakou G et al. Procalcitonin as a parameter of infection in febrile neutropenia. 3rd International Symposium on Febrile Neutropenia. Brussels, Belgium, 1997, abstract 15.
18. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605-8.
19. The EORTC International Antimicrobial Therapy Cooperative Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. New Engl J Med 1987;317:1692-8.
20. Rolston KVI, Berkey P, Bodey GP, Anaissie EJ, Khardori NM, Joshi JH, Keating MJ, Holmes FA, Cabanillas FF, Elting L. A comparison of imipenem to ceftaizidime with or without amikacin as empiric therapy in febrile neutropenic patients. Arch Intern Med 1992; 152: 283-91.
21. Leibovici L, Paul M, Poznanski O, Drucker M, Samra Z, Konigsberger H, et al. Monotherapy vs. β-lactam-aminoglycoside combination treatment for Gram-negative bacteremia: a prospective observational study. Antimicrob Agents Chemother 1997; 41: 1127-33.